(IN BRIEF) The British Heart Foundation has awarded £7.1 million to fund the CHAIN consortium, a national PhD training programme focused on understanding the critical link between heart and brain diseases. Delivered collaboratively by the University of Manchester, University of … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Non Profit, Science, Technology, United Kingdom
Tagged Alastair Poole, artificial intelligence, atrial fibrillation, British Heart Foundation, cardiovascular disease, CHAIN consortium, data science, Deirdre Lane, Gina Galli, Healthcare Innovation, heart brain axis, Louise Kenny, Multidisciplinary CHAIN Programme Aims to Transform Understanding of Heart Brain Connections in Modern Medicine, multidisciplinary research, myocardial infarction, neurological disease, personalised medicine, PhD programme, University of Bristol, University of Liverpool, University of Liverpool Joins Major BHF-Funded Initiative to Train Future Leaders in Cardiovascular and Brain Science, University of Manchester, vascular dementia
(IN BRIEF) New data presented at EHRA 2026 show that individuals with atrial fibrillation detected through screening face a threefold higher risk of developing heart failure compared with those without AF, with a risk level similar to patients with known … Read the full press release
Posted in Business, Education, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Society, Technology
Tagged AF screening, asymptomatic AF, atrial fibrillation, cardiology, cardiovascular disease, clinical research, ECG screening, EHRA 2026, EHRA 2026 Study Shows Screening Identified AF Carries Similar Heart Failure Risk as Diagnosed Cases, European Heart Rhythm Association, European Society of Cardiology, Gina Sado, heart failure, patient outcomes, STROKESTOP, STROKESTOP II
(IN BRIEF) Fraunhofer IPA is developing a digital assistance system through the GenderHeart project to improve aftercare and early detection of cardiovascular disease in women, who face higher mortality rates after heart attacks and strokes compared to men. The system … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Science, Technology
Tagged artificial intelligence, biosensors, cardiovascular disease, digital health, Early Detection, ECG monitoring, Fraunhofer IPA, gender-specific medicine, GenderHeart project, healthcare technology, heart attack, hormone factors, Medical Innovation, Paula Röttig, risk assessment, stroke, TEDIAS, University Medical Centre Mannheim, voice analysis, Women’s Health, Zana Technologies GmbH
(IN BRIEF) New research published in the European Heart Journal reveals that even short periods of vigorous physical activity can significantly reduce the risk of major diseases, including heart disease, diabetes, inflammatory conditions, and dementia. The study, based on data … Read the full press release
Posted in Business, Education, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Society, Technology
Tagged accelerometer study, Arthritis, cardiovascular disease, chronic disease prevention, dementia, Diabetes and Cardiovascular Disease, European Heart Journal, European Society of Cardiology, exercise intensity, health research, inflammation, International Research Suggests Small Amounts of Vigorous Activity Can Improve Long-Term Health Outcomes, lifestyle health, Minxue Shen, mortality risk, physical activity, public health, Study Finds Exercise Intensity Plays Key Role in Lowering Risk of Dementia, type 2 diabetes, UK Biobank, vigorous exercise
(IN BRIEF) University of Copenhagen researchers have found that poor dental health during childhood is associated with a higher risk of cardiovascular disease and type 2 diabetes later in life. The study, based on data from more than 568,000 individuals … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, Science, Technology
Tagged cardiovascular disease, childhood health, cohort study, Coronary Artery Disease, Danish Health Authority, dental caries, epidemiology, gingivitis, heart attack, inflammation, Large Danish Study Shows Childhood Tooth Decay and Gum Disease Associated with Future Cardiovascular Risk, Merete Markvart, National Child Odontology Registry, National Patient Register, Nikoline Nygaard, oral health, preventive dentistry, stroke, type 2 diabetes, University of Copenhagen, University of Copenhagen Research Highlights Long Term Health Impact of Childhood Tooth Decay and Gingivitis
(IN BRIEF) Data presented at EAPCI Summit 2026 analysing 21 European countries found no significant link between higher national rates of primary PCI procedures and reduced mortality following myocardial infarction, suggesting that access alone does not determine outcomes. The research … Read the full press release
Posted in Business, Education, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Ali Malik, cardiometabolic risk, cardiovascular disease, EAPCI Summit 2026, ESC Atlas of Cardiology, European Association of Percutaneous Cardiovascular Interventions, European healthcare data, European Society of Cardiology, healthcare systems research, interventional cardiology, King’s College London, mortality analysis, Mount Sinai Health System, myocardial infarction, New Multi Country Study Highlights Systemic Factors Beyond Procedure Numbers in Reducing Cardiovascular Mortality, Pan European Data Review Points to Prevention Expertise and Care Pathways as Key Drivers of Cardiac Outcomes, percutaneous coronary intervention, Prevention Strategies, primary PCI, Sanjay Sivalokanathan, Sukruth Pradeep Kundur
(IN BRIEF) Sanofi has secured regulatory approval in China for two innovative medicines, Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome. The approvals expand treatment options for patients with serious cardiovascular and rare metabolic diseases and underscore … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Security & Safety, Technology
Tagged aficamten, cardiovascular disease, China NMPA, clinical phase 3 trials, familial chylomicronemia syndrome, FCS, Greater China, innovative medicines, Myqorzo, obstructive hypertrophic cardiomyopathy, oHCM, Olivier Charmeil, plozasiran, rare diseases, Redemplo, Sanofi, Sanofi Strengthens China Portfolio with Approval of Two Innovative Therapies for oHCM and FCS, siRNA therapy
(IN BRIEF) An international panel of more than 80 experts has issued updated recommendations for managing atrial fibrillation, reflecting conclusions from the 10th AFNET/EHRA Consensus Conference. Published in EP Europace, the guidance calls for a shift toward integrated, patient-centred care … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, France, Healthcare, Industrial, Investment, Management, Science, Technology
Tagged AFNET, Andreas Goette, artificial intelligence in cardiology, atrial fibrillation, cardiac arrhythmia, cardiovascular disease, comorbidity management, EHRA, Emma Svennberg, EP Europace, EU Horizon 2020, European Heart Rhythm Association, International Experts Call for Integrated, Jose Luis Merino, MAESTRIA, patient-centred care, Patient-Centred Care in Atrial Fibrillation, Paulus Kirchhof, rhythm control therapy, risk assessment, stroke prevention
(IN BRIEF) A study by the Technical University of Munich and Harvard Medical School has shown that obesity drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) reduce the risk of hospitalization or death in patients with heart failure with preserved ejection … Read the full press release
Posted in Business, Education, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged cardiovascular disease, Diabetes, German Heart Center, Harvard Medical School, Health Data Utilization Act, heart failure, heart failure with preserved ejection fraction, Heribert Schunkert, HFpEF, hospitalization, JAMA, mortality reduction, Mounjaro, Nils Krüger, obesity drugs, Ozempic, partnership, Semaglutide, Technical University of Munich, tirzepatide, TUM, Wegovy
(IN BRIEF) Research presented at ESC Congress 2025 has shown that low fitness and older age independently increase the risk of arrhythmias in otherwise healthy adults. The study of 1,151 participants aged 40–65 revealed that reduced aerobic capacity was strongly … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Investment, Management, Marketing, Media, News, Science, Spain, Technology
Tagged aerobic fitness, aging, arrhythmias, atrial arrhythmias, cardiovascular disease, Cardiovascular risk, Chaim Sheba Medical Center, Dr Amit Moses, Early Detection, ECG monitoring, ESC Congress 2025, European Society of Cardiology, exercise and heart health, heart rhythm, irregular heartbeat, preventive cardiology, screening over 50s, ventricular arrhythmias
(IN BRIEF) A doctoral study at the University of Helsinki shows that women with a history of pre-eclampsia face significantly higher risks of cardiovascular disease later in life, but hormone therapy used during menopause can help reduce this risk while … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, Marketing, News, Technology
Tagged cardiovascular disease, doctoral thesis, Finland, hormone therapy, hypertensive pregnancy disorders, ischaemic heart disease, menopause, Minttu Venetkoski, Naistenklinikka, pre-eclampsia, stroke risk, University of Helsinki, Women’s Health
(IN BRIEF) Novartis will present 19 abstracts at the 2025 European Society of Cardiology (ESC) Congress in Madrid, showcasing new findings across its cardiovascular portfolio. Key highlights include two VictORION studies on Leqvio’s impact on quality of life and its … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged abelacimab, atrial fibrillation, AZALEA-TIMI 71, cardiovascular disease, cardiovascular pipeline therapies, Chagas disease, Entresto, ESC Congress 2025, European Society of Cardiology, heart failure, inclisiran, Leqvio, lipoprotein apheresis, lipoprotein(a), Lp(a)FRONTIERS APHERESIS trial, Novartis, PARACHUTE-HF trial, pelacarsen, Sacubitril Valsartan, VictORION studies, xRNA platform
(IN BRIEF) A large-scale study of more than 36,000 people with high blood pressure has shown that walking more steps daily, even below 10,000, and increasing walking pace can significantly reduce the risk of heart and vascular problems. Each extra … Read the full press release
Posted in Business, France, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged accelerometer study, cardiovascular disease, daily steps, Emmanuel Stamatakis, European Journal of Preventive Cardiology, European Society of Cardiology, heart disease, heart failure, High blood pressure, hypertension, MACE, Mackenzie Wearables Research Hub, myocardial infarction, physical activity, stroke, UK Biobank, University of Sydney, walking pace
(IN BRIEF) A team at the Technical University of Munich has uncovered a potential new explanation for sex-based differences in age-related diseases. Their study found that as female mice age, genes on the silenced second X chromosome become active again. … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged ACE2, age-related diseases, aging, Barr body, cardiovascular disease, Daniel Andergassen, dementia, epigenetics, Nature Aging, neurodegenerative disorders, Parkinson's, Sarah Hoelzl, sex differences, sex-based health differences, Technical University of Munich, TLR8, TUM, X chromosome
(IN BRIEF) Roche has launched a CE-marked Chest Pain Triage algorithm developed with Universitätsklinikum Heidelberg to improve emergency diagnosis of chest pain. Integrated into the navify® Algorithm Suite, the tool uses high-sensitivity cardiac troponin testing and ESC guidelines to support … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged acute coronary syndrome, AI in healthcare, cardiac diagnostics, cardiovascular disease, CE-marked IVD, Chest Pain Triage Algorithm, digital diagnostics, digital health, EHR integration, emergency department, ESC guidelines, Healthcare Innovation, high-sensitivity troponin, hospital workflow optimization, Matt Sause, medical device, navify Algorithm Suite, patient triage, Roche, Universitätsklinikum Heidelberg
(IN BRIEF) The EU-funded DORIAN GRAY project, with the University of Liverpool as a key scientific partner, is set to explore the link between cardiovascular disease (CVD) and mild cognitive impairment (MCI). Despite one in three CVD patients experiencing MCI, … Read the full press release
Posted in Education, Healthcare, Science, Society, United Kingdom
Tagged AI, biomarkers, cardiovascular disease, clinical trial, cognitive training, CVD, dementia reduction, digital tool, DORIAN GRAY, Dr Riccardo Proietti, EU-funded, heart failure, Horizon Europe, international collaboration, Liverpool Clinical Trials Centre, MCI, medical avatar, mild cognitive impairment, Prevention Strategies, Professor Carrol Gamble, risk model, University of Brescia, University of Liverpool
(IN BRIEF) The DataTools4Heart (DT4H) project, funded under the European Union’s Horizon Europe Framework, has successfully concluded its initial development phase and is set to achieve major milestones in 2025. Focused on enhancing the lifestyle of cardiovascular disease patients, DT4H … Read the full press release
Posted in Artificial Intelligence (AI), European Union, France, Healthcare, Industrial, Italy, Management, News, Pharma & Biotech, Science, Technology
Tagged AI-powered analytics, Barcelona Supercomputing Center, cardiology data reuse, cardiovascular disease, clinical data, clinician engagement, Cristian Izquierdo, data synthesis, DataTools4Heart, DT4H, eight hospitals, ESC Congress, European Union, federated learning, Horizon Europe, Laura G. Antiga, multilingual natural language processing, privacy-preserving, secure toolkit, Sophia Antipolis, stable software, unified interface, University of Barcelona
(IN BRIEF) The ESC Preventive Cardiology 2025 Congress will be held in Milan from 3 to 5 April 2025 and is organized by the European Association of Preventive Cardiology, part of the ESC. The event will feature over 120 sessions … Read the full press release
Posted in Business, European Union, France, Healthcare, Industrial, Law, Management, News, Pharma & Biotech, Science
Tagged 3 April 2025, 5 April 2025, artificial intelligence, breakthrough interventions, cancer therapy-induced toxicity, cardiovascular disease, data science, diagnostics, digital cardiac rehabilitation, ESC Preventive Cardiology 2025, European Association of Preventive Cardiology, European Society of Cardiology, gender differences, heart health, interactive workshops, Italian Federation of Cardiology, Italian Strategic Plan for Cardiovascular Health, Italy, live cases, Milan, Nicolle Kränkel, Obesity, Pharmacology, press accreditation, press conference, preventive cardiology, primary prevention, public health, rehabilitation, risk estimation tools, secondary prevention, sports cardiology
(IN BRIEF) A collaborative study led by Bayer and Hurdle, in partnership with top academic institutions including the University of Birmingham and the University of Edinburgh, has introduced and validated InflammAge—a novel, non-invasive saliva-based biomarker that quantifies systemic chronic inflammation, … Read the full press release
Posted in Business, Education, European Union, Financial, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged aging, Bayer, Cancer, cardiovascular disease, chronic inflammation, CRP, Dr. Daniel Martin-Herranz, Generation Scotland, Hurdle, InflammAge, lifestyle factors, neurodegenerative disorders, non-invasive testing, partnership, precision medicine, Professor Janet M Lord, Professor Riccardo E. Marioni, remote health monitoring, saliva-based DNA methylation biomarker, University of Birmingham, University of Edinburgh, Veronika Óvári
(IN BRIEF) Recent studies suggest that current cardiovascular risk assessment methods may be inadequate and call for a more personalized approach. Tools like carotid ultrasound offer promising solutions for more precise evaluations, enabling targeted interventions such as aspirin therapy, which … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged aspirin therapy, Bayer, cardiovascular disease, cardiovascular health, Cardiovascular risk, carotid ultrasound, coronary artery calcium scoring, Dr. Michael Blaha, Dr. Ricardo Salazar, healthcare access, heart disease prevention, ischemic events, medical research, personalized medicine, risk assessment, stroke prevention, subclinical atherosclerosis, subclinical plaque
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?